Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;35(11):1859-67.
doi: 10.1007/s00134-009-1610-5. Epub 2009 Aug 7.

Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients

Affiliations

Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients

Caroline Guignant et al. Intensive Care Med. 2009 Nov.

Abstract

Purpose: Improvements in survival after septic shock will most likely rely on our capacity to manage individualized therapies based on the measurement of rapidly accessible biomarkers. As the early phase of septic shock is dominated by severe alterations of the cardiovascular system, the predictive value for mortality of pro-vasopressin (pro-AVP) and pro-adrenomedullin (pro-ADM), two vasoactive pro-hormones, was assessed.

Methods: In 99 consecutive patients, pro-hormone concentrations were measured (immunoluminometric assay) three times within the first week after the onset of septic shock.

Results: Pro-AVP and pro-ADM concentrations were significantly increased in non-survivors in comparison with survivors and were significantly associated with mortality after both univariate and multivariate analysis. Importantly, when assessed as a pair, pro-ADM and pro-AVP were even more informative.

Conclusions: Both Pro-ADM and pro-AVP appear to be good biomarkers for the prediction of 28-day mortality after septic shock. However, their association in a single variable tends to improve their predictive capacity.

PubMed Disclaimer

Comment in

References

    1. Crit Care Med. 2007 May;35(5):1244-50 - PubMed
    1. N Engl J Med. 2003 Jan 9;348(2):138-50 - PubMed
    1. Crit Care Med. 2004 Sep;32(9):1928-48 - PubMed
    1. JAMA. 1992 Dec 23-30;268(24):3452-5 - PubMed
    1. Crit Care. 2005;9(6):R816-24 - PubMed

Publication types

MeSH terms

LinkOut - more resources